(Q45039047)

8 December 2017

title

Immunotherapy dispenses with tumor antigens (English)

1 reference

8 December 2017

1 reference

1

Soldano Ferrone

1 reference

8 December 2017

publication date

1 September 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

22

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

1096-1098

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt0904-1096

8 December 2017

exact match

0 references

cites work

Current developments in cancer vaccines and cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

A simple method to cure established tumors by inflammatory killing of normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

The makings of a tumor rejection antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

Monoclonal antibodies as therapeutic agents for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

The TRAIL to selective tumor death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

Immunotherapy of melanoma: the good news, the bad ones and what to do next

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

inferred from DOI database lookup

7 January 2021

based on heuristic

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

inferred from DOI database lookup

7 January 2021

based on heuristic

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1038%2FNBT0904-1096

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NBT0904-1096

1 reference

Dimensions Publication ID

8 December 2017

1026819333

0 references

1 reference